Upload Avatar (500 x 500)
韩曙
Medical School
浙江大学
浙江
Language: 中文, 英语
神经解剖
神经生物学
脊髓损伤
神经保护
炎症
神经退行性疾病
肌萎缩侧索硬化症
帕金森病
阿尔茨海默病
神经炎症
Areas of Focus
- 神经解剖与神经生物学
Work Experience
- 2003.7—至今 浙江大学医学院基础医学系，人体解剖学课程组/神经科学研究中心
- 2006.7—2008.7 访问学者: 美国肯塔基州脊髓损伤研究中心
Academic Background & Achievements
- 1995.9~1998.7 硕士学位: 新疆医科大学
- 1998.9~2001.7 博士学位: 中山医科大学
- 2001.9~2003.7 博士后研究: 上海第二医科大学
Publications
- Angiopoietin-1 and ανβ3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex model, Cai HY, Tian KW, Zhang YY, Jiang H, Han S, 2018
- C16 Peptide Promotes Vascular Growth and Reduces Inflammation in a Neuromyelitis Optica Model, Chen H, Fu X, Jiang J, Han S, 2019
- C16 peptide and angiopoietin-1 protect against LPS-induced BV-2 microglial cell inflammation, Fu X, Chen H, Han S, 2020
- Contribution of Thrombospondin-1 and -2 to Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome, Li Q, Fu X, Yuan J, Han S, 2021
- Combined treatment with C16 peptide and angiopoietin-1 confers neuroprotection and reduces inflammation in 3-nitropropionic acid-induced dystonia mice, Fu XX, Cai HY, Jiang H, Han S, 2021
- Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson's disease, Cai HY, Fu XX, Jiang H, Han S, 2021
- Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment, Fu XX, Wang J, Cai HY, Jiang H, Jiang JZ, Chen HH, Han S, 2022
- C16 Peptide and Ang-1 Improve Functional Disability and Pathological Changes in an Alzheimer's Disease Model Associated with Vascular Dysfunction, Fu X, Wang J, Cai H, Jiang H, Han S, 2022
- Combination Treatment of C16 Peptide and Angiopoietin-1 Alleviates Neuromyelitis Optica in an Experimental Model, Zhang YY, Tian KW, Jiang H, Wang BB, Han S, 2018
- Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal stem cell therapy for EAE, Tian KW, Zhang YY, Jiang H, Han S, 2018
